Measurement of left ventricular ejection fraction using gated 99mTc-sestamibi myocardial planar images: comparison to contrast ventriculography.

Using the new myocardial perfusion agent 99mTc-sestamibi and multigated acquisition on a nuclear medicine gamma camera, the left ventricular ejection fraction (LVEF) was derived in 13 patients with coronary artery disease (CAD). Cross-sectional activity profiles were used to measure the left ventricle from end-diastolic and end-systolic images. Several different geometric methods were then utilized to derive ejection fractions from the nuclear data. Comparison of the resultant ejection fractions to those obtained from contrast ventriculography showed significant correlation for all geometric methods (P less than 0.01, Sy X x = 6.2 to 9.6). We conclude that in patients with CAD one or more of these simple geometric methods can provide a useful estimate of the LVEF when performing 99mTc-sestamibi multigated myocardial perfusion imaging.

[1]  R H Jones,et al.  Perfusion and function at rest and treadmill exercise using technetium-99m-sestamibi: comparison of one- and two-day protocols in normal volunteers. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  L. Becker,et al.  Myocardial redistribution of technetium-99m-methoxyisobutyl isonitrile (SESTAMIBI). , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  I. Mena,et al.  Simultaneous assessment of left ventricular wall motion and myocardial perfusion with technetium-99m-methoxy isobutyl isonitrile at stress and rest in patients with angina: comparison with thallium-201 SPECT. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  B. Holman,et al.  Effect of metabolic inhibition on technetium-99m-MIBI kinetics in cultured chick myocardial cells. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  P. Marzullo,et al.  A new method for noninvasive quantitation of segmental myocardial wall thickening using technetium-99m 2-methoxy-isobutyl-isonitrile scintigraphy--results in normal subjects. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  S. Treves,et al.  Comparison of technetium-99m MIBI and thallium-201 chloride myocardial scintigraphy in infants. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  D. Berman,et al.  Comparison of technetium 99m methoxy isobutyl isonitrile and thallium 201 for evaluation of coronary artery disease by planar and tomographic methods. , 1989, American heart journal.

[8]  I. Mena,et al.  Simultaneous technetium-99m MIBI angiography and myocardial perfusion imaging. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  J. Heo,et al.  New myocardial perfusion imaging agents: description and applications. , 1988, American heart journal.

[10]  J. Maublant,et al.  Hexakis (2-methoxy isobutylisonitrile) technetium-99m and thallium-201 chloride: uptake and release in cultured myocardial cells. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  G M Pohost,et al.  Of linens and laces--the eighth anniversary of the gated blood pool scan. , 1979, Seminars in nuclear medicine.

[12]  J. Murray,et al.  Myocardial Imaging with Thallium-201 at Rest and during Exercise , 1977, Circulation.